<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2019-1-33-40</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-96</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Склеральные газопроницаемые контактные линзы как возможный способ зрительной реабилитации пациентов с возрастной макулярной дегенерацией (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Scleral gas permeable contact lenses as a possible way of visual rehabilitation of patients with age-related macular degeneration</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мягков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Myagkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, директор</p><p>125438, Москва, ул. Михалковская, д. 63Б, стр. 4</p></bio><bio xml:lang="en"><p>Med.Sc.D., Professor, Director</p><p>63B, bld. 4 Mikhalkovskaya, Moscow, 125438, Russian Federation</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковалевская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalevskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, заведующая кафедрой офтальмологии</p><p>394036, Воронеж, ул. Студенческая, 10</p></bio><bio xml:lang="en"><p>Med.Sc.D., Professor, Head of the Ophthalmology Department</p><p>10 Studencheskaya st., Voronezh, 394036, Russian Federation</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перерва</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pererva</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перерва Оксана Александровна, клинический ординатор</p><p>125438, Москва, ул. Михалковская, д. 63Б, стр. 4</p></bio><bio xml:lang="en"><p>Clinical resident</p><p>63B, bld. 4 Mikhalkovskaya, Moscow, 125438, Russian Federation</p></bio><email xlink:type="simple">oxana.pererva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НОЧУ ДПО «Академия медицинской оптики и оптометрии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academy of Medical Optics and Optometry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Воронежский государственный медицинский университет им. Н.Н. Бурденко» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Voronezh State Medical University named after N.N. Burdenko</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>02</day><month>10</month><year>2019</year></pub-date><volume>21</volume><issue>1 (125)</issue><fpage>33</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/96">https://www.theeyeglaz.com/jour/article/view/96</self-uri><abstract><p>Снижение качества остроты зрения у пациентов с возрастной макулярной дегенерацией (ВМД) обусловлено наличием низкой остроты зрения, выпадением центрального поля зрения, метаморфопсиями, искажением линий, снижением контрастности. Существующие на данный момент способы вспомогательной коррекции зрения у пациентов с ВМД, такие как телескопические интраокулярные и склеральные линзы, функционально и косметически неприемлемы. Использование интраокулярных телескопических линз ограничивается большим риском послеоперационных осложнений, низкими функциональными показателями, а также затруднённой офтальмоскопией и длительной адаптацией пациентов. Телескопические склеральные линзы имеют низкое разрешение, газонепроницаемые части и требуют ношения специальных переключающих очков. Однако склеральные линзы обладают потенциалом в разработке оптимального метода коррекции зрения у пациентов с ВМД за счет наличия широкой оптической зоны, газопроницаемости, коррекции рефракционного астигматизма у пресбиопических пациентов и облегчения симптомов сухости глаз. Таким образом, требуются дальнейшие клинические исследования по разработке метода улучшения качества зрения у пациентов с ВМД с помощью склеральных линз с применением объективного метода оценки эффективности коррекции – 3D-компьютерного порогового теста Амслера (3D-CTAG).</p></abstract><trans-abstract xml:lang="en"><p>Low visual acuity, loss of the central visual field, metamorphopsia, distortion of lines and decreased contrast sensitivity cause reduced quality of vision in patients with age-related macular degeneration (AMD). Currently existing methods of visual rehabilitation for patients with AMD, such as telescopic intraocular and scleral lenses, are functionally and cosmetically unacceptable. The use of intraocular telescopic lenses is limited by the high risk of postoperative complications, low functional parameters, as well as by difficult ophthalmoscopy and lasting adaptation of patients. Telescopic scleral lenses have а low resolution, contain parts impermeable to oxygen and require wearing special switching glasses. However, scleral lenses have potential in developing an optimal method for vision correction in patients with AMD due to the presence of following advantages: wide optical zone, gas permeability, correction of refractive astigmatism in presbyopic patients and alleviation of dry eye symptoms. In conclusion, further clinical research is required to develop a method for improving the quality of vision in patients with AMD by using scleral lenses with an objective test for evaluating the effectiveness of correction – the 3D computer-automated threshold Amsler grid test (3D-CTAG). </p></trans-abstract><kwd-group xml:lang="ru"><kwd>ВМД</kwd><kwd>склеральные контактные линзы</kwd><kwd>оптическая коррекция</kwd><kwd>слабовидение</kwd><kwd>телескопические очки</kwd><kwd>оптическая реабилитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>AMD</kwd><kwd>scleral contact lenses</kwd><kwd>optical correction</kwd><kwd>low vision</kwd><kwd>telescopic spectacles</kwd><kwd>optical rehabi-litation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Coleman H.R. et al. Age-related macular degeneration. The Lancet. 2008;372(9652):1835-1845. doi:10.1016/S0140-6736(08)61759-6</mixed-citation><mixed-citation xml:lang="en">Coleman H.R. et al. Age-related macular degeneration. The Lancet. 2008;372(9652):1835-1845. doi:10.1016/S0140-6736(08)61759-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wong W.L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. 2014;2(2):e106-e116. doi:10.1016/S2214-109X(13)70145-1</mixed-citation><mixed-citation xml:lang="en">Wong W.L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. 2014;2(2):e106-e116. doi:10.1016/S2214-109X(13)70145-1</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bourne R.A. et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. The Lancet Glo-bal Health. 2013;1(6):e339-e349. doi:10.1016/S2214-109X(13)70113-X</mixed-citation><mixed-citation xml:lang="en">Bourne R.A. et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. The Lancet Glo-bal Health. 2013;1(6):e339-e349. doi:10.1016/S2214-109X(13)70113-X</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Roh M. et al. Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. PloS One. 2018;13(5). e0196481. doi: 10.1371/journal.pone.0196481</mixed-citation><mixed-citation xml:lang="en">Roh M. et al. Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration. PloS One. 2018;13(5). e0196481. doi: 10.1371/journal.pone.0196481</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Xu K. et al. Metamorphopsia and vision-related quality of life among patients with age-related macular dege-neration. Can J Ophthalmol. 2018; 53(2):168-172. doi: 10.1016/j.jcjo.2017.08.006</mixed-citation><mixed-citation xml:lang="en">Xu K. et al. Metamorphopsia and vision-related quality of life among patients with age-related macular dege-neration. Can J Ophthalmol. 2018; 53(2):168-172. doi: 10.1016/j.jcjo.2017.08.006</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Owsley C., Sloane М.Е. Contrast sensitivity, acuity and the perception of real world targets. Br J Ophthalmol. 1987;71:791–796.</mixed-citation><mixed-citation xml:lang="en">Owsley C., Sloane М.Е. Contrast sensitivity, acuity and the perception of real world targets. Br J Ophthalmol. 1987;71:791–796.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt-Erfurth U. et al. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE stu-dy. Ophthalmology. 2011;118(5):831-839. doi: 10.1016/j.ophtha.2010.09.004</mixed-citation><mixed-citation xml:lang="en">Schmidt-Erfurth U. et al. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE stu-dy. Ophthalmology. 2011;118(5):831-839. doi: 10.1016/j.ophtha.2010.09.004</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell P. et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol. 2010;94(1):2-13. doi:10.1136/bjo.2009.159160</mixed-citation><mixed-citation xml:lang="en">Mitchell P. et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol. 2010;94(1):2-13. doi:10.1136/bjo.2009.159160</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaiser P.K. et al. Ranibizumab for predominantly clas-sic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144(6):850-857. doi: 10.1016/j.ajo.2007.08.012</mixed-citation><mixed-citation xml:lang="en">Kaiser P.K. et al. Ranibizumab for predominantly clas-sic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144(6):850-857. doi: 10.1016/j.ajo.2007.08.012</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Holz F.G. et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143(3):463-472. e2.</mixed-citation><mixed-citation xml:lang="en">Holz F.G. et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143(3):463-472. e2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sunness J.S., Applegate C.A. Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration. Am J Ophthalmol. 2005;140(6):1085-1093. doi:10.1136/bjo.2009.159160/</mixed-citation><mixed-citation xml:lang="en">Sunness J.S., Applegate C.A. Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration. Am J Ophthalmol. 2005;140(6):1085-1093. doi:10.1136/bjo.2009.159160/</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fletcher D.C. Scanning laser ophthalmoscope macular perimetry and applications for low vision rehabilitation clinicians. Ophthamol Clin North Am. 1994;7:257-265.</mixed-citation><mixed-citation xml:lang="en">Fletcher D.C. Scanning laser ophthalmoscope macular perimetry and applications for low vision rehabilitation clinicians. Ophthamol Clin North Am. 1994;7:257-265.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung S.H., Legge G.E. Functional and cortical adaptations to central vision loss. Vis Neuroscience. 2005;22(2):187–201.</mixed-citation><mixed-citation xml:lang="en">Cheung S.H., Legge G.E. Functional and cortical adap-tations to central vision loss. Vis Neuroscience. 2005;22(2):187–201.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Педанова Е.К. Ценность микропериметрии как метода оценки эффективности лечения у пациентов с очень низкими зрительными функциями. Современные технологии в офтальмологии. 2014;1:81-82.</mixed-citation><mixed-citation xml:lang="en">Pedanova E.K. The value of microperimetry as a method for evaluating the effectiveness of treatment in patients with very low visual functions. Modern Technology in Ophthalmology. 2014;1:81-82. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ковалевская М.А., Богатырева Е.С., Милюткина С.О. Комбинированная функциональная диагностика при болезни Беста. Российский медицинский журнал. Клиническая офтальмология. 2013:4:181-184.</mixed-citation><mixed-citation xml:lang="en">Kovalevskaya M.A., Bogatyreva E.S., Milyutkina S.O. Combined functional diagnostics of Best dystrophy. Russian medical journal. Clinical Ophthalmology. 2013:4:181-184. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Amsler M. L’examen qualitatif de la fonction maculaire. Ophthalmologica. 1947;114:248-261.</mixed-citation><mixed-citation xml:lang="en">Amsler M. L’examen qualitatif de la fonction maculaire. Ophthalmologica. 1947;114:248-261.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bolz M. et al. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Br J Ophthalmol. 2010;94(2):185-189. doi: 10.1136/bjo.2008.143974</mixed-citation><mixed-citation xml:lang="en">Bolz M. et al. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Br J Ophthalmol. 2010;94(2):185-189. doi: 10.1136/bjo.2008.143974</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kovalevskaya M. et al. 3D-CTAG testing of functional and structural changes of the macula. AOVS. 2016;4(2):00103. doi: 10.15406/aovs.2016.04.00103</mixed-citation><mixed-citation xml:lang="en">Kovalevskaya M. et al. 3D-CTAG testing of functional and structural changes of the macula. AOVS. 2016;4(2):00103. doi: 10.15406/aovs.2016.04.00103</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grzybowski A. et al. Intraocular lenses in age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol. 2017;255(9):1687-1696. doi:10.1007/s00417-017-3740-8</mixed-citation><mixed-citation xml:lang="en">Grzybowski A. et al. Intraocular lenses in age-related macular degeneration. Graefe’s Arch Clin Exp Ophthalmol. 2017;255(9):1687-1696. doi:10.1007/s00417-017-3740-8</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Arianpour,A. et al. Wearable telescopic contact lens. Applied optics. 2015;54(24):7195-7204. doi: 10.1364/AO.54.007195</mixed-citation><mixed-citation xml:lang="en">Arianpour A. et al. Wearable telescopic contact lens. Applied optics. 2015;54(24):7195-7204. doi: 10.1364/AO.54.007195</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Orzalesi N. et al. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860-865. doi: 10.1016/j.ophtha.2007.01.005</mixed-citation><mixed-citation xml:lang="en">Orzalesi N. et al. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860-865. doi: 10.1016/j.ophtha.2007.01.005</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal A. et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and preli-minary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008; 34(1):87-94. doi:10.1016/j.jcrs.2007.08.031</mixed-citation><mixed-citation xml:lang="en">Agarwal A. et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and preli-minary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008; 34(1):87-94. doi:10.1016/j.jcrs.2007.08.031</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts B. et al. Higher order aberrations induced by soft contact lenses in normal eyes with myopia. Eye &amp; Contact Lens. 2006;32(3):138-142. doi:10.1097/01.icl.0000195570.73454.a5</mixed-citation><mixed-citation xml:lang="en">Roberts B. et al. Higher order aberrations induced by soft contact lenses in normal eyes with myopia. Eye &amp; Contact Lens. 2006;32(3):138-142. doi:10.1097/01.icl.0000195570.73454.a5</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Мягков А.В., Игнатова Н.В. Наш опыт оптической коррекции последствий радиальной кератотомии с помощью склеральных линз. Клинические случаи. Российский офтальмологический журнал. 2017; 10(2):92-96. doi: 10.21516/2072-0076-2017-10-2-92-96</mixed-citation><mixed-citation xml:lang="en">Myagkov A.V., Ignatova N.V. Our experience in optical correction of radial keratotomy consequences by scleral lenses. Clinical cases. Russian Ophthalmological Journal. 2017;10 (2):92-96. (In Russ.) doi: 10.21516/2072-0076-2017-10-2-92-96</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Belda-Salmerón L., Drew T., Hall L., Wolffsohn J.S. Objective analysis of contact lens fit. Cont Lens Anterior Eye. 2015;38(3):163-167.</mixed-citation><mixed-citation xml:lang="en">Belda-Salmerón L., Drew T., Hall L., Wolffsohn J.S. Objective analysis of contact lens fit. Cont Lens Anterior Eye. 2015;38(3):163-167.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Young C., Kading D.L., Brujic M. Strategies for Success with Specialty Multifocal Contact Lenses. Go beyond the rack to customize lenses to meet the needs of your presbyopic patients. Review of Cornea and Contact Lenses. 2013.</mixed-citation><mixed-citation xml:lang="en">Young C., Kading D.L., Brujic M. Strategies for Success with Specialty Multifocal Contact Lenses. Go beyond the rack to customize lenses to meet the needs of your presbyopic patients. Review of Cornea and Contact Lenses. 2013.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Worp Eef. A Guide to scleral lens fitting. 2015.</mixed-citation><mixed-citation xml:lang="en">Van der Worp Eef. A Guide to scleral lens fitting. 2015.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Arianpour A. et al. Wearable telescopic contact lens. Applied Optics. 2015;54(24):7195-7204. doi: 10.1364/AO.54.007195</mixed-citation><mixed-citation xml:lang="en">Arianpour A. et al. Wearable telescopic contact lens. Applied Optics. 2015;54(24):7195-7204. doi: 10.1364/AO.54.007195</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Isen A. Feinbloom miniscope contact lens. Encyclopedia of Contact Lens Practice. 1963;13:53-55.</mixed-citation><mixed-citation xml:lang="en">Isen A. Feinbloom miniscope contact lens. Encyclopedia of Contact Lens Practice. 1963;13:53-55.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schuster G.M. et al. Wink-controlled polarization-switched telescopic contact lenses. Applied Optics. 2015;54(32):9597-9605. doi: 10.1364/AO.54.009597</mixed-citation><mixed-citation xml:lang="en">Schuster G.M. et al. Wink-controlled polarization-switched telescopic contact lenses. Applied Optics. 2015;54(32):9597-9605. doi: 10.1364/AO.54.009597</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Butt T. et al. Simulation contact lenses for AMD health state utility values in NICE appraisals: A different reality. Br J Ophthalmol. 2015;99(4):540-544. doi: 10.1136/bjophthalmol-2014-305802</mixed-citation><mixed-citation xml:lang="en">Butt T. et al. Simulation contact lenses for AMD health state utility values in NICE appraisals: A different reality. Br J Ophthalmol. 2015;99(4):540-544. doi: 10.1136/bjophthalmol-2014-305802</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Jivrajka R.V. et al. Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing. Graefe’s Arch Clin Exp Ophthalmol. 2009;247(2):165-170. doi:10.1007/s00417-008-0971-8</mixed-citation><mixed-citation xml:lang="en">Jivrajka R.V. et al. Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing. Graefe’s Arch Clin Exp Ophthalmol. 2009;247(2):165-170. doi:10.1007/s00417-008-0971-8</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
